By Evan Weinberger ( August 30, 2010, 3:25 PM EDT) -- A federal appeals court was wrong to rule in a class action against Matrixx Initiatives Inc. that drug companies must inform shareholders of all adverse event reports linked to a drug, a biotechnology industry group has said in an amicus brief to the U.S. Supreme Court....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.